TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.75
0.00 (0.00%)
Apr 2, 2025, 1:30 PM CST

TPEX:4157 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
150.65123.1336.231,29523.42
Upgrade
Revenue Growth (YoY)
22.35%239.87%-97.20%5426.95%15.30%
Upgrade
Cost of Revenue
16.1311.453.7412.724.04
Upgrade
Gross Profit
134.52111.6932.491,28219.39
Upgrade
Selling, General & Admin
90.5598.972.6499.0677.27
Upgrade
Research & Development
166.07187.48237.52283.28249.44
Upgrade
Operating Expenses
256.62286.39310.16382.34326.71
Upgrade
Operating Income
-122.1-174.7-277.67899.46-307.32
Upgrade
Interest Expense
-1.42-1.14-0.85-0.24-0.6
Upgrade
Interest & Investment Income
24.420.388.724.233.5
Upgrade
Earnings From Equity Investments
----23.24-113.04
Upgrade
Currency Exchange Gain (Loss)
54.17-15.6851.79-4.2413.08
Upgrade
Other Non Operating Income (Expenses)
0.48149.40.010.04-
Upgrade
EBT Excluding Unusual Items
-44.47-21.73-218876-404.38
Upgrade
Gain (Loss) on Sale of Investments
13.55165.220.30.080.43
Upgrade
Gain (Loss) on Sale of Assets
----0.080.01
Upgrade
Asset Writedown
-1.96--12.06--2.92
Upgrade
Pretax Income
-32.89143.49-229.77875.99-406.87
Upgrade
Income Tax Expense
5.76.767.4100.37-2.06
Upgrade
Net Income
-38.58136.73-237.16775.62-404.82
Upgrade
Net Income to Common
-38.58136.73-237.16775.62-404.82
Upgrade
Shares Outstanding (Basic)
717717717717717
Upgrade
Shares Outstanding (Diluted)
717717717717717
Upgrade
Shares Change (YoY)
0.03%0.06%-0.07%0.07%0.01%
Upgrade
EPS (Basic)
-0.050.19-0.331.08-0.56
Upgrade
EPS (Diluted)
-0.050.19-0.331.08-0.56
Upgrade
Free Cash Flow
-173.623.57-24.66618.83-247.56
Upgrade
Free Cash Flow Per Share
-0.240.01-0.030.86-0.34
Upgrade
Gross Margin
89.29%90.70%89.69%99.02%82.77%
Upgrade
Operating Margin
-81.05%-141.88%-766.41%69.48%-1312.10%
Upgrade
Profit Margin
-25.61%111.04%-654.61%59.91%-1728.37%
Upgrade
Free Cash Flow Margin
-115.25%2.90%-68.06%47.80%-1056.95%
Upgrade
EBITDA
-113.76-164.59-267.53909.9-295.49
Upgrade
EBITDA Margin
-75.51%-133.67%-70.29%-
Upgrade
D&A For EBITDA
8.3410.1110.1410.4411.83
Upgrade
EBIT
-122.1-174.7-277.67899.46-307.32
Upgrade
EBIT Margin
-81.05%-141.88%-69.48%-
Upgrade
Effective Tax Rate
-4.71%-11.46%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.